[1] TSUSHIMA K,KING L S,AGGARWAL N R,et al. Acute lung injury review[J]. Int Med,2009,48(9):621-630.[2] BUTT Y,KURDOWSKA A,ALLEN T C. Acute lung injury:A clinical and molecular review[J]. Arch Pathol Lab Med,2016,140(4):345-350.[3] MATTHAY M A,WARE L B,ZIMMERMAN G A. The acute respiratory distress syndrome[J]. J Clin Invest,2012,122(8):2731-2740.[4] MODRYKAMIEN A M,GUPTA P. The acute respiratory distress syndrome[J]. Proc (Bayl Univ Med Cent),2015,28(2):163-171.[5] WHEELER A P,BERNARD G R. Acute lung injury and the acute respiratory distress syndrome:a clinical review[J]. Lancet,2007,369(9572):1553-1564.[6] HAYES M,CURLEY G,ANSARI B,et al. Clinical review:Stem cell therapies for acute lung injury/acute respiratory distress syndrome-hope or hype?[J]. Crit Care,2012,16(2):205.[7] BERNARD G R,ARTIGAS A,BRIGHAM K L,et al. The American- European Consensus Conference on ARDS. Definitions,mechanisms,relevant outcomes,and clinical trial coordination[J]. Am J Respir Crit Care Med,1994,149(3 Sup 1):818-824.[8] 中华医学会重症医学分会. 急性肺损伤/急性呼吸窘迫综合征诊断和治疗指南(2006)[J]. 中华急诊医学杂志,2007,16(4):1-6.[9] RANIERI V M,RUBENFELD G D,THOMPSON B T,et al. Acute respiratory distress syndrome:the Berlin definition[J]. JAMA,2012,307(23):2526-2533.[10] PERL M,LOMAS-NEIRA J,VENET F,et al. Pathogenesis of indirect (secondary) acute lung injury[J]. Expert Rev Respir Med,2011,5(1):115-126.[11] RUBENFELD G D,CALDWELL E,PEABODY E,et al. Incidence and outcomes of acute lung injury[J]. N Engl J Med,2005,353(16):1685-1693.[12] LU Y,SONG Z,ZHOU X,et al. A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care units[J]. Intensive Care Med,2004,30(12):2197-2203.[13] 北京市科委重大项目MODS课题组. 1998-2003年北京地区重症加强治疗病房急性呼吸窘迫综合征的临床流行病学调查[J]. 中华危重病急救医学,2007,19(4):201-204.[14] 任志慧,章志丹,穆恩,等. 急性肺损伤/急性呼吸窘迫综合征的流行病学调查分析[C]//中华医学会第五次全国重症医学大会论文集. 广州,2011.[15] SEKI H,TASAKA S,FUKUNAGA K,et al. Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury[J]. Inflamm Res,2010,59(10):837-845.[16] PATEL B V,WILSON M R,O'DEA K P,et al. TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury[J]. J Immunol,2013,190(8):4274-4282.[17] PIERRAKOS C,KARANIKOLAS M,SCOLLETTA S,et al. Acute respiratory distress syndrome:pathophysiology and therapeutic options [J]. J Clin Med Res,2012,4(1):7-16.[18] MIYOSHI K,YANAGI S,KAWAHARA K,et al. Epithelial Pten controls acute lung injury and fibrosis by regulating alveolar epithelial cell integrity[J]. Am J Respir Crit Care Med,2013,187(3):262-275.[19] WARD P A,GRAILER J J. Acute lung injury and the role of histones [J]. Transl Respir Med,2014,2:1.[20] BAO H,GAO F,XIE G,et al. Angiotensin-converting enzyme 2 inhibits apoptosis of pulmonary endothelial cells during acute lung injury through suppressing MiR-4262[J]. Cell Physiol Biochem,2015,37(2):759-767.[21] LIU S,TANG J,HUANG L,et al. Cordyceps militaris alleviates severity of murine acute lung injury through miRNAs-mediated CXCR2 inhibition[J]. Cell Physiol Biochem,2015,36(5):2003-2011.[22] DENG X,JIN K,LI Y,et al. Platelet-derived growth factor and transforming growth factor beta1 regulate ARDS-associated lung fibrosis through distinct signaling pathways[J]. Cell Physiol Biochem,2015,36(3):937-946.[23] SONG J,LU H,ZHENG X,et al. Effects of vascular endothelial growth factor in recovery phase of acute lung injury in mice[J]. Lung,2015,193(6):1029-1036.[24] WILLIAMS A E,CHAMBERS R C. The mercurial nature of neutrophils:still an enigma in ARDS?[J]. Am J Physiol Lung Cell Mol Physiol,2014,306(3):217-230.[25] CASTILLO R L,CARRASCO LOZA R,ROMERO-DAPUETO C. Pathophysiological approaches of acute respiratory distress syndrome:Novel bases for study of lung injury[J]. Open Respir Med J,2015,9:83-91.[26] LEE W L,DOWNEY G P. Neutrophil activation and acute lung injury[J]. Curr Opin Crit Care,2001,7(1):1-7.[27] ZAMJAHN J B,QUINTON L J,MACK J C,et al. Differential flux of macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant from the lung after intrapulmonary delivery[J]. Am J Physiol Lung Cell Mol Physiol,2011,301(4):568-574.[28] JANDL K,STACHER E,BALINT Z,et al. Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung[J]. J Allergy Clin Immunol,2016,137(3):833-843.[29] HEROLD S,MAYER K,LOHMEYER J. Acute lung injury:how macrophages orchestrate resolution of inflammation and tissue repair[J]. Front Immunol,2011,2:65.[30] LIANG J,JUNG Y,TIGHE R M,et al. A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury[J]. Am J Physiol Lung Cell Mol Physiol,2012,302(9):933-940.[31] BECK-SCHIMMER B,SCHWENDENER R,PASCH T,et al. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury[J]. Respir Res,2005,6:61.[32] HEROLD S,TABAR T S,JANSSEN H,et al. Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia[J]. Am J Respir Crit Care Med,2011,183(10):1380-1390.[33] SEBAG S C,BASTARACHE J A,WARE L B. Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome[J]. Curr Pharm Biotechnol,2011,12(9):1481-1496.[34] KOTANIDOU A,LOUTRARI H,PAPADOMICHELAKIS E,et al. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice[J]. Vascul Pharmacol,2006,45(2):134-140.[35] NIEUWENHUIZEN L,DE GROOT P G,GRUTTERS J C,et al. A review of pulmonary coagulopathy in acute lung injury,acute respiratory distress syndrome and pneumonia[J]. Eur J Haematol,2009,82(6):413-425.[36] WHITE C W,RANCOURT R C,VERESS L A. Sulfur mustard inhalation:mechanisms of injury,alteration of coagulation,and fibrinolytic therapy[J]. Ann N Y Acad Sci,2016,1378(1):87-95.[37] CHEN Y,LU Z J,YANG Y,et al. Suppression of plasminogen activator inhibitor-1 by inhaled nitric oxide attenuates the adverse effects of hyperoxia in a rat model of acute lung injury[J]. Thromb Res,2015,136(1):131-138.[38] CAUDRILLIER A,KESSENBROCK K,GILLISS B M,et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury[J]. J Clin Invest,2012,122(7):2661-2671.[39] MUKHOPADHYAY S,HOIDAL J R,MUKHERJEE T K. Role of TNFalpha in pulmonary pathophysiology[J]. Respir Res,2006,7:125.[40] TANG M,TIAN Y,LI D,et al. TNF-alpha mediated increase of HIF-1alpha inhibits VASP expression,which reduces alveolar-capillary barrier function during acute lung injury (ALI)[J]. PLoS One,2014,9(7):e102967.[41] LI T,LUO N,DU L,et al. Tumor necrosis factor-alpha plays an initiating role in extracorporeal circulation-induced acute lung injury[J]. Lung,2013,191(2):207-214.[42] KONRAD F M,REUTERSHAN J. CXCR2 in acute lung injury[J]. Mediators Inflamm,2012. doi:10.1155/2012/740987.[43] REED M,MORRIS S H,OWCZARCZYK A B,et al. Deficiency of autophagy protein Map1-LC3b mediates IL-17-dependent lung pathology during respiratory viral infection via ER stress-associated IL-1[J]. Mucosal Immunol,2015,8(5):1118-1130.[44] LI Q,GU Y,TU Q,et al. Blockade of interleukin-17 restrains the development of acute lung injury[J]. Scand J Immunol,2016,83(3):203-211.[45] LODA E,BALABANOV R. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination[J]. Rev Neurosci,2012,23(2):145-152.[46] WU D,PAN P,SU X,et al. Interferon regulatory factor-1 mediates alveolar macrophage pyroptosis during LPS-induced acute lung injury in mice[J]. Shock (Augusta,Ga),2016,46(3):329-338.[47] JING W,CHUNHUA M,SHUMIN W. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-kappaB pathway in vivo and in vitro[J]. Toxicol Appl Pharmacol,2015,285(2):128-135.[48] FAN Z,YAO J,LI Y,et al. Anti-inflammatory and antioxidant effects of curcumin on acute lung injury in a rodent model of intestinal ischemia reperfusion by inhibiting the pathway of NF-κB[J]. Int J Clin Exp Pathol,2015,8(4):3451-3459.[49] CHICOINE L G,STENGER M R,CUI H,et al. Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells[J]. Am J Physiol Lung Cell Mol Physiol,2011,300(4):596-604.[50] GILL S E,ROHAN M,MEHTA S. Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo[J]. Respir Res,2015,16:109.[51] CAHILL P A,REDMOND E M. Vascular endothelium-Gatekeeper of vessel health[J]. Atherosclerosis,2016,248:97-109.[52] YANG K Y,LIU K T,CHEN Y C,et al. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients:a prospective observational study[J]. Crit Care,2011,15(1):11.[53] CALFEE C S,GALLAGHER D,ABBOTT J,et al. Plasma angiopoietin-2 in clinical acute lung injury:prognostic and pathogenetic significance[J]. Crit Care Med,2012,40(6):1731-1737.[54] GALLAGHER D C,PARIKH S M,BALONOV K,et al. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome[J]. Shock (Augusta,Ga),2008,29(6):656-661.[55] WARE L B,MATTHAY M A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome[J]. Am J Respir Crit Care Med,2001,163(6):1376-1383.[56] OLSON N,HRISTOVA M,HEINTZ N H,et al. Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction[J]. Am J Physiol Lung Cell Mol Physiol,2011,301(6):993-1002.[57] OVERGAARD C E,DAUGHERTY B L,MITCHELL L A,et al. Claudins:control of barrier function and regulation in response to oxidant stress[J]. Antioxid Redox Signal,2011,15(5):1179-1193. |